Loading provider…
Loading provider…
Medical Oncology Physician in New York, NY
NPI: 1346211141Primary Employer
Memorial Solid Tumor Group
mskcc.org
HQ Phone
Get MD Shanu's Phone Numberphone_androidMobile
Get MD Shanu's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
2022
NJ State Medical License
2020 - 2027
NY State Medical License
2004 - 2025
University of Alberta
Medical School
Until 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 141 | 290 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 24 | 24 |
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.
Authors: Maura Dickler, Larry Norton, Chau Dang, Clifford Hudis, Bob Li, Neil Vasan, Edi Brogi, Mark Robson, Pedram Razavi, Sarat Chandarlapaty, Dara Ross, Tiffany Traina, David Hyman, Komal Jhaveri, Michael Cheng
Journal: Cancer Cell
Interaction of EDTA with horseradish peroxidase: 1H-NMR study.
Authors: Modi S
Publication Date: 1993-03
Authors: Howard Burris, Muralidhar Beeram, Ian Krop
Journal: J Clin Oncol
Publication Date: 2010-04-26
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Novartis
Intervention / Treatment: DRUG: BYL719, DRUG: TRASTUZUMAB, DRUG: LJM716
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: National Cancer Institute (NCI), New York University Cancer Institute, Synta Pharmaceuticals Corp.
Intervention / Treatment: BIOLOGICAL: trastuzumab, DRUG: paclitaxel, BIOLOGICAL: pertuzumab, DRUG: ganetespib
Lead Sponsor: Seagen Inc.
Intervention / Treatment: DRUG: Trastuzumab, DRUG: ladiratuzumab vedotin